Which has the lower trailing P/E, CHE or LGND?

CHE has the lower trailing P/E: CHE trades at 25.63 and LGND at 31.72. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CHE or LGND?

Over the past five years, CHE grew revenue faster — CHE at a 4.12% CAGR versus LGND at 2.92%.

Does CHE or LGND pay a bigger dividend?

CHE pays a dividend (0.49% yield), while LGND is a former payer with no current dividend run rate.

Is CHE or LGND more profitable?

LGND runs the higher net margin — CHE at 10.60% versus LGND at 67.88%.

How have CHE and LGND total returns compared?

Over the past 10 years, CHE delivered 14.19% and LGND delivered 17.12% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs Ligand Pharmaceuticals Incorporated (LGND)

A side-by-side comparison of Chemed Corporation and Ligand Pharmaceuticals Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.67B

$510.59HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

LGND

Ligand Pharmaceuticals Incorporated

$5.94B

$296.57HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

Total return — CHE vs LGND

growth of $100 · dividends reinvested · last 10y

CHE +280.2% (+14.3%/yr)LGND +389.0% (+17.2%/yr)LGND compounded faster over this window

CHE LGND

CHE vs LGND: by the numbers

•CHE is the larger company ($6.67B vs $5.94B market cap).
•CHE trades at the lower trailing earnings multiple (25.63 vs 31.72 P/E), one valuation lens rather than an overall verdict.
•LGND converts more revenue to profit (67.88% vs 10.60% net margin).
•CHE grew revenue faster over the past five years (4.12% vs 2.92% CAGR).
•CHE pays a dividend (0.49% yield), while LGND is a former payer with no current dividend run rate.

Metrics side by side

Valuation

Metric	CHE	LGND
P/E ratio	25.63	31.72
Forward P/E	20.03	31.87
P/S ratio	2.57	20.46
P/B ratio	8.04	6.14
EV / EBITDA	16.75	44.96
FCF yield	4.85%	2.21%

Profitability

Metric	CHE	LGND
Gross margin	30.44%	98.58%
Operating margin	13.46%	17.61%
Net margin	10.60%	67.88%
ROE	33.11%	20.38%
ROIC	19.48%	3.91%

Dividends

Metric	CHE	LGND
Dividend yield	0.49%	N/A
Payout ratio	12.55%	N/A

Growth (annualized)

Metric	CHE	LGND
Revenue CAGR (5Y)	4.12%	2.92%
EPS CAGR (5Y)	-1.65%	N/A
FCF CAGR (5Y)	-5.44%	-0.49%
Total return CAGR (5Y)	3.58%	30.72%

Frequently asked

Which has the lower trailing P/E, CHE or LGND?: CHE has the lower trailing P/E: CHE trades at 25.63 and LGND at 31.72. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CHE or LGND?: Over the past five years, CHE grew revenue faster — CHE at a 4.12% CAGR versus LGND at 2.92%.
Does CHE or LGND pay a bigger dividend?: CHE pays a dividend (0.49% yield), while LGND is a former payer with no current dividend run rate.
Is CHE or LGND more profitable?: LGND runs the higher net margin — CHE at 10.60% versus LGND at 67.88%.
How have CHE and LGND total returns compared?: Over the past 10 years, CHE delivered 14.19% and LGND delivered 17.12% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full LGND analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio Ligand Pharmaceuticals P/E ratio Chemed dividend yield Chemed ROE Ligand Pharmaceuticals ROE Chemed operating margin Ligand Pharmaceuticals operating margin Chemed revenue growth Ligand Pharmaceuticals revenue growth Chemed free cash flow Ligand Pharmaceuticals free cash flow

Chemed & Ligand Pharmaceuticals appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.